This report contains market size and forecasts of Tofacitinib in global, including the following market information:
Global Tofacitinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tofacitinib Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Tofacitinib companies in 2021 (%)
The global Tofacitinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5mg*60 Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tofacitinib include Pfizer, Globe Pharmaceuticals, Delta Pharma Limited, Beacon Pharmaceuticals and Drug International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tofacitinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tofacitinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tofacitinib Market Segment Percentages, by Type, 2021 (%)
5mg*60 Tablets
5mg*10 Tablets
10mg*10 Tablets
5mg*30 Tablets
5mg*14 Tablets
10mg*14 Tablets
Global Tofacitinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tofacitinib Market Segment Percentages, by Application, 2021 (%)
Rheumatoid Arthritis
Ulcerative Colitis
Psoriasis
Other
Global Tofacitinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tofacitinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tofacitinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tofacitinib revenues share in global market, 2021 (%)
Key companies Tofacitinib sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Tofacitinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Globe Pharmaceuticals
Delta Pharma Limited
Beacon Pharmaceuticals
Drug International